EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expansion of pneumococcal serotype 23F and 14 lineages with genotypic changes in capsule polysaccharide locus and virulence gene profiles post introduction of pneumococcal conjugate vaccine in Blantyre, Malawi

Rory Cave, Akuzike Kalizang'oma, Chrispin Chaguza, Thandie S Mwalukomo, Arox Kamng'ona, Comfort Brown, Jacquline Msefula, Farouck Bonomali, Roseline Nyirenda, Todd D Swarthout, Brenda Kwambana-Adams, Neil French und 1 weitere

Microbial Genomics · 2024

DOI: 10.1099/mgen.0.001264 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Genomics, 2024. Verfasst von Rory Cave und 12 weiteren Autor:innen. Beteiligte Einrichtung: Mucosal Pathogens Research Group, Research Department of Infection, Division of Infection & Immunity, University College London, London, UK. Hauptthemen laut MEDLINE: Streptococcus pneumoniae, Pneumococcal Vaccines, Serogroup, Bacterial Capsules. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Bill and Melinda Gates Foundation, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) in Malawi in 2011, there has been persistent carriage of vaccine serotype (VT) Streptococcus pneumoniae , despite high vaccine coverage. To determine if there has been a genetic change within the VT capsule polysaccharide (cps) loci since the vaccine’s introduction, we compared 1022 whole-genome-sequenced VT isolates from 1998 to 2019. We identified the clonal expansion of a multidrug-resistant, penicillin non-susceptible serotype 23F GPSC14-ST2059 lineage, a serotype 14 GPSC9-ST782 lineage and a novel serotype 14 sequence type GPSC9-ST18728 lineage. Serotype 23F GPSC14-ST2059 had an I253T mutation within the capsule oligosaccharide repeat unit polymerase Wzy protein, which is predicted in silico to alter the protein pocket cavity. Moreover, serotype 23F GPSC14-ST2059 had SNPs in the DNA binding sites for the cps transcriptional repressors CspR and SpxR. Serotype 14 GPSC9-ST782 harbours a non-truncated version of the large repetitive protein (Lrp), containing a Cna protein B-type domain which is also present in proteins associated with infection and colonisation. These emergent lineages also harboured genes associated with antibiotic resistance, and the promotion of colonisation and infection which were absent in other lineages of the same serotype. Together these data suggest that in addition to serotype replacement, modifications of the capsule locus associated with changes in virulence factor expression and antibiotic resistance may promote vaccine escape. In summary, the study highlights that the persistence of vaccine serotype carriage despite high vaccine coverage in Malawi may be partly caused by expansion of VT lineages post-PCV13 rollout.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Streptococcus pneumoniaePneumococcal VaccinesSerogroupBacterial CapsulesPneumococcal InfectionsHumansMalawiVaccines, ConjugatePolysaccharides, BacterialVirulenceGenotypeWhole Genome SequencingBacterial ProteinsVirulence FactorsChild, PreschoolPolymorphism, Single NucleotideInfantMale

Stichwörter der Autor:innen

AfricaCapsule polysaccharide locusPCV13Streptococcus pneumoniaeantimicrobial resistancevaccine escape

Substanzen

Pneumococcal Vaccines13-valent pneumococcal vaccineVaccines, ConjugatePolysaccharides, BacterialBacterial ProteinsVirulence Factors

Autor:innen und Institutionen

  • Mucosal Pathogens Research Group, Research Department of Infection, Division of Infection & Immunity, University College London, London, UK.
  • Malawi Liverpool Wellcome Programme, Blantyre, Malawi.
  • Parasites and Microbes, Wellcome Sanger Institute, Cambridge, UK.
  • Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, CT, USA.
  • Kamuzu University of Health Sciences, Blantyre, Malawi.
  • Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, Netherlands.

Förderung

  • Wellcome Trust
  • Bill and Melinda Gates Foundation
  • Medical Research Council

Zitieren

APA

Cave, R., Kalizang'oma, A., Chaguza, C., Mwalukomo, T. S., Kamng'ona, A., Brown, C., Msefula, J., Bonomali, F., Nyirenda, R., Swarthout, T. D., Kwambana-Adams, B., French, N., & Heyderman, R. S. (2024). Expansion of pneumococcal serotype 23F and 14 lineages with genotypic changes in capsule polysaccharide locus and virulence gene profiles post introduction of pneumococcal conjugate vaccine in Blantyre, Malawi. Microbial Genomics. https://doi.org/10.1099/mgen.0.001264

Vancouver

Cave R, Kalizang'oma A, Chaguza C, Mwalukomo TS, Kamng'ona A, Brown C, et al. Expansion of pneumococcal serotype 23F and 14 lineages with genotypic changes in capsule polysaccharide locus and virulence gene profiles post introduction of pneumococcal conjugate vaccine in Blantyre, Malawi. Microbial Genomics. 2024. doi:10.1099/mgen.0.001264

BibTeX
@article{Cave2024,
  author = {Cave, Rory and Kalizang'oma, Akuzike and Chaguza, Chrispin and Mwalukomo, Thandie S and Kamng'ona, Arox and Brown, Comfort and Msefula, Jacquline and Bonomali, Farouck and Nyirenda, Roseline and Swarthout, Todd D and Kwambana-Adams, Brenda and French, Neil and Heyderman, Robert S},
  title = {Expansion of pneumococcal serotype 23F and 14 lineages with genotypic changes in capsule polysaccharide locus and virulence gene profiles post introduction of pneumococcal conjugate vaccine in Blantyre, Malawi},
  journal = {Microbial Genomics},
  year = {2024},
  doi = {10.1099/mgen.0.001264}
}
Kostenlos starten →